Pillstats
Rx only · Tablet, Film Coated · Oral

Amlodipine And Olmesartan Medoxomil

Amlodipine Besylate + Olmesartan Medoxomil

8 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US28 NDCs
8 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers8 labelers
Packages59
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 22 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.089$0.177$0.266$0.354Dec 2025Mar 2026Jun 2026
$0.286
Latest avg · Jun 17, 2026
-5%
Since Dec 17, 2025
8
Active US suppliers
47%
Top-2 supplier share*

Who makes it8 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Macleods Pharmaceuticals Limitedunknown16SUPPLYING
Glenmark Pharmaceuticals Inc., USAunknown12SUPPLYING
ScieGen Pharmaceuticals, Inc.unknown12SUPPLYING
Camber Pharmaceuticals, Inc.unknown6SUPPLYING
AvKAREunknown4SUPPLYING
Aurobindo Pharma Limitedunknown4SUPPLYING
Amneal Pharmaceuticals LLCunknown4SUPPLYING
A-S Medication Solutionsunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.